A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition

NCT04592822 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Anticoagulant

Interventions

DRUG: WD-1602
DRUG: Pradaxa®

Sponsor

Hong Kong WD Pharmaceutical Co., Limited